Insight Molecular Diagnostics (IMDX) vs Q/C Technologies (QCLS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Insight Molecular Diagnostics is the larger company by market cap ($107.3 million vs $5.2 million), about 20.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMDX | QCLS |
|---|---|---|
| Share price | $3.28 | $0.6367 |
| Market cap | $107.34M | $5.21M |
| 1-day change | -5.20% | +0.74% |
| YTD return | -56.27% | — |
| 1-year return | -10.87% | — |
| 5-year return | -95.18% | — |
| P/E ratio (TTM) | — | 0.24 |
| EPS (TTM) | $-1.52 | $2.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.51 | $8.17 |
| 52-week low | $2.42 | $0.42 |
| Distance from 52-week high | -61.46% | -92.21% |
| Analyst consensus | none | — |
| Avg. price target upside | +151.52% | — |
| Average volume | 232.87K | 4.98M |
| Shares outstanding | 32.72M | 8.19M |
| Employees | 55 | 3 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Insight Molecular Diagnostics is about 20.6 times larger than Q/C Technologies by market value ($107.34M vs $5.21M).
About Insight Molecular Diagnostics
IMDX stock →Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 55 employees
About Q/C Technologies
QCLS stock →Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 3 employees
IMDX vs QCLS FAQ
Which is bigger, Insight Molecular Diagnostics or Q/C Technologies?
Insight Molecular Diagnostics (IMDX) is larger, with a market capitalization of $107.34M compared with $5.21M for Q/C Technologies (QCLS).
Are Insight Molecular Diagnostics and Q/C Technologies in the same industry?
Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.